Cui, Lin <br/><br/>
Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer.  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2014 
 - 1699-702 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.7314/apjcp.2014.15.4.1699  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemoradiotherapy<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Paclitaxel--adverse effects<br/>Radiotherapy, Conformal<br/>Survival Rate